Laboratory and clinical predictors of thrombosis and hemorrhage in 29 pediatric extracorporeal membrane oxygenation nonsurvivors

Pediatric and Developmental Pathology

Volumn 13, Issue 5, 2010, Pages 385-392

  Reed, Robyn C ^a   Rutledge, Joe C ^b  

^a KOSAIR CHILDREN'S HOSPITAL   (United States)

^b SEATTLE CHILDREN S HOSPITAL   (United States)

Author keywords

Autopsy; Blood coagulation tests; Coagulation; Extracorporeal membrane oxygenation; Hemorrhage; Thrombosis

Indexed keywords

FIBRINOGEN; HEPARIN;

ABDOMINAL BLEEDING; ARTICLE; AUTOPSY; BLEEDING; BRAIN HEMORRHAGE; CLINICAL ARTICLE; CONGENITAL DIAPHRAGM HERNIA; CONGENITAL HEART DISEASE; DEATH; DISEASE ASSOCIATION; EXTRACORPOREAL OXYGENATION; FEMALE; FIBRINOGEN BLOOD LEVEL; HEART INFARCTION; HEMATOTHORAX; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INFANT; LABORATORY TEST; LUNG DISEASE; LUNG HEMORRHAGE; MALE; MYOCARDITIS; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; RESPIRATORY SYNCYTIAL VIRUS INFECTION; SEPSIS; THERAPY EFFECT; THROMBOCYTE COUNT; THROMBOSIS; TREATMENT DURATION; TREATMENT OUTCOME; CONGENITAL HEART MALFORMATION; NEWBORN; RISK FACTOR;

EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HEART DEFECTS, CONGENITAL; HEMORRHAGE; HUMANS; INFANT; INFANT, NEWBORN; MALE; RISK FACTORS; THROMBOSIS;

EID: 79952201981     PISSN: 10935266     EISSN: 16155742     Source Type: Journal    
DOI: 10.2350/09-09-0704-OA.1     Document Type: Article

References (23)

1. Alsoufi B, Al-Radi OO, Nazer RI, et al. Survival outcomes after rescue extracorporeal cardiopulmonary resuscitation in pediatric patients with refractory cardiac arrest. J Thorac Cardiovasc Surg 2007;134:952-959.
2. Annich GM, Miskulin J. Coagulation, Anticoagulation, and the Interaction of Blood and Artificial Surfaces. In: Van Meurs K, Lally KP, Peek G, Zwischenberger JP, eds. ECMO Extracorporeal Cardiopulmonary Support in Critical Care. Ann Arbor, MI: Extracorporeal Life Support Organization, 2005.
3. Urlesberger B, Zobel G, Zenz W, et al. Activation of the clotting system during extracorporeal membrane oxygenation in term newborn infants. J Pediatr 1996;129:264-268. (Pubitemid 27483799)
4. Robinson TM, Kickler TS, Walker LK, Ness P, Bell W. Effect of extracorporeal membrane oxygenation on platelets in newborns. Crit Care Med 1993;21:1029-1034. (Pubitemid 23206195)
5. Haines NM, Rycus PT, Zwischenberger JB, Bartlett RH, Undar A. Extracorporeal Life Support Registry report 2008: neonatal and pediatric cardiac cases. ASAIO J 2009;55:111-6.
6. Conrad SA, Rycus PT, Dalton H. Extracorporeal Life Support Registry report 2004. ASAI J 2005;51:4-10.
7. Zwischenberger JB, Nguyen TT, Upp JR et al. Complications of neonatal extracorporeal membrane oxygenation: collective experience from the Extracorporeal Life Support Organization. J Thorac Cardiovasc Surg 1994;107:838-849. (Pubitemid 24100462)
8. Hirthler MA, Blackwell E, Abbe D, et al. Coagulation parameter instability as an early predictor of intracranial hemorrhage during extracorporeal membrane oxygenation. J Pediatr Surg 1992;27:40-43.
9. Chou P, Blei ED, Shen-Schwarz S, Gonzalez-Crussi F, Reynolds M. Pulmonary changes following extracorporeal membrane oxygenation: autopsy study of 23 cases. Hum Pathol 1993;24:405-412. (Pubitemid 23127257)
10. Weber TR, Westfall SH, Sotelo C, Vogler CA, Tracy T. A clinical-pathological study of nonsurvivors of newborn ECMO. J Pediatr Surg 1993;28:135-137. (Pubitemid 23064328)
11. Jarjour IT, Ahdab-Barmada M. Cerebrobascular lesions in infants and children dying after extracorporeal membrane oxygenation. Pediatr Neurol 1994;10:13-19. (Pubitemid 24096715)
12. Vogler C, Sotelo-Avila C, Lagunoff D, Braun P, Schreifels JA, Weber T. Aluminum-containing emboli in infants treated with extracorporeal membrane oxygenation. New Engl J Med 1988;319: 75-79.
13. Fink SM, Bockman DE, Howell CG, Falls DG, Kanto WP. Bypass circuits as the source of thromboemboli during extracorporeal membrane oxygenation. J Pediatr 1989;115:621-624. (Pubitemid 19248847)
14. Jacobs ML, Pourmoghadam KK. Thromboembolism and the role of anticoagulation in the Fontan patient. Pediatr Cardiol 2007;28: 457-464. (Pubitemid 350160290)
15. Odegard KC, McGowan FX, Zurakowski D, et al. Procoagulant and anticoagulant factor abnormalities following the Fontan procedure: increased factor VIII may predispose to thrombosis. J Thorac Cardiovasc Surg 2003;125:1260-1267. (Pubitemid 36759223)
16. Odegard KC, Zurakowski D, Hornykewycz S, et al. Evaluation of the coagulation system in children with two-ventricle congenital heart disease. Ann Thorac Surg 2007;83:1797-1804.
17. Odegard KC, Zurakowski D, DiNardo JA, et al. Prospective longitudinal study of coagulation profiles in children with hypoplastic left heart syndrome from stage I through Fontan completion. J Thorac Cardiovasc Surg 2009;137:934-941.
18. Sell LL, Cullen ML, Whittlesey GC, et al. Hemorrhagic complications during extracorporeal membrane oxygenation: prevention and treatment. J Pediatr Surg 1986;21:1087-1091. (Pubitemid 17187896)
19. Dela Cruz TV, Steward DL, Winston SJ, Weatherman KS, Phelps JL, Mendoza JC. Risk factors for intracranial hemorrhage in the extracorporeal membrane oxygenation patient. J Perinatol 1997;17: 18-23. (Pubitemid 127452396)
20. Bartlett RH, Gazzaniga AB, Jefferies MR, Huxtable RF, Haiduc NJ, Fong SW. Extracorporeal membrane oxygenation (ECMO) cardiopulmonary support in infancy. Trans Am Soc Artif Intern Organs 1976;22:80-93.
21. Baird CW, Zurakowski D, Robinson B, et al. Anticoagulation and pediatric extracorporeal membrane oxygenation: impact of activated clotting time and heparin dose on survival. Ann Thorac Surg 2007; 83:912-920. (Pubitemid 46328806)
22. Zavadil DP, Stammers AH, Willett LD, Deptula JJ, Christensen KA, Sydzyik RT. Hematological abnormalities in neonatal patients treated with extracorporeal membrane oxygenation (ECMO). J Extra Corpor Technol 1998;30:83-90. (Pubitemid 28337781)
23. Stammers AH, Willett L, Fristoe L, et al. Coagulation monitoring during extracorporeal membrane oxygenation: the role of thromboelastrography. J Extra Corpor Technol 1995;17:137-145.